跳至主要内容
临床试验/CTRI/2018/06/014614
CTRI/2018/06/014614已完成未知

Development of a dosing algorithm using pharmacogenetic and clinical variables for optimizing anticoagulant therapy in patients on warfarin.

Dr Nusrat Shafiq0 个研究点目标入组 82 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adult patients of atrial fibrillation and patients requiring valve replacement surgeries on chronic anticoagulation therapy with warfarin

排除标准

  • 1. Patients with known contraindications to anticoagulant therapy,
  • 2. Patients of transient atrial fibrillation secondary to reversible disorders such as thyrotoxicosis, cardiothoracic surgery and severe anaemia,
  • 3. Patients with underlying hepatic (defined as elevation in alanine/ aspartate transaminase >2.5 times the upper limit of normal) and or severe renal insufficiency(defined as creatinine clearance of <30ml/min),
  • 4. Pregnant and nursing women,
  • 5. Patients unwilling to participate in the study.

研究者

发起方
Dr Nusrat Shafiq

相似试验